Company: SNY
Filing Date: 2025-07-10
Form Type: SC TO-T/A
Source: 0001193125-25-157299
Chunk: 2

Company: Sanofi
Filing Date: 2025-07-10
Form: SC TO-T/A
Chunk 2
---
 information set forth in the Offer to Purchase, including Schedule I thereto, is incorporated by reference herein in response to Items 1 through 9 and Item 11 of this Schedule TO and is supplemented by the information specifically provided in this Amendment, except as otherwise set forth below. This Amendment should be read together with the Schedule TO. Capitalized terms used and not otherwise defined in this Amendment have the meanings given to such terms in the Offer to Purchase. Items 1 through 9 and Item 11. The Offer to Purchase and Items 1 through 9 and Item 11 of the Schedule TO, to the extent such Items incorporate by reference the information contained in the Offer to Purchase, are hereby amended and supplemented as follows:

| (1) | The second paragraph of the subsection entitled “Antitrust Compliance” in Section 16 –                                                         
 “Certain Legal Matters; Regulatory Approvals” is amended and supplemented by deleting the second paragraph and adding the following paragraph: |

“Under the HSR Act, the purchase of Shares may not be completed until the expiration of a 30-calendar daywaiting period following the filing of certain required information and documentary material concerning the Offer with the FTC and the Antitrust Division, unless the waiting period is earlier terminated by the FTC and the Antitrust Division. The waiting period under the HSR Act expired, effective July 9, 2025 at 11:59 p.m., Eastern Time. Accordingly, the condition to the Offer requiring that the waiting period (or any extension thereof) applicable to the Offer and the Merger under the HSR Act shall have expired or been terminated has been satisfied.”

| (2) | The subsection entitled “Austria Merger Control Compliance” in Section 16 – “Certain                                                                                           
 Legal Matters; Regulatory Approvals” is amended and supplemented by deleting the last sentence of the paragraph and adding the following sentence at the end of the paragraph: |

“The expiry of the statutory (Phase I) waiting period occurred on July 8, 2025 (24:00 Central European Time).”

| (3) | The subsection entitled “Germany Merger Control Compliance” in Section 16 – “Certain                               
 Legal Matters; Regulatory Approvals” is deleted and is amended and supplemented by adding the following paragraph: |

“Under part I chapter VII of the Act against Restraints of Competition (“ ARC”), certain acquisitions, including the Purchaser’s purchase of Shares pursuant to the Offer, may not be consummated until certain information has been furnished for review by the Federal Cart